Peter Aldous – 2014 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Peter Aldous on 2014-06-04.
To ask the Secretary of State for Health, what steps NHS England takes to consider (a) all new specialised service applications and (b) new treatments for Alpha-1 Antitrypsin Deficiency; and whether such steps are subject to review by his Department.
Norman Lamb
The Prescribed Specialised Services Advisory Group (PSSAG) is a Department expert committee which was set up to provide regular advice to Ministers on which services are specialised and should be prescribed in regulations for national commissioning by the NHS Commissioning Board (NHS England). The Group met most recently in May 2014 and may meet up to four times a year.
Evidence, supporting information and activity on those services currently prescribed in legislation for direct commissioning by NHS England and any new services identified as potentially specialised, are made available to PSSAG from a range of sources, which may include Clinical Reference Groups (CRGs), patient groups, clinicians, commissioners and members of the public. The proposals the group considers are in large part generated by NHS England through its CRGs. The PSSAG makes recommendations to Ministers who, before deciding whether to make regulations, consult with NHS England, as required by section 3B of the National Health Service Act 2006.
NHS England advises that where it becomes the responsible commissioner for a service, it considers the funding priority of the service through its clinical priorities advisory group and manages a process for selecting providers. Any highly specialised services that become the commissioning responsibility of NHS England will be discussed at its Rare Disease Advisory Group.
The commissioning of services for people with alpha 1-antitrypsin deficiency is a matter for individual clinical commissioning groups. We understand the Alpha 1 Alliance is working with NHS England and the Specialised Respiratory Clinical Reference Group to develop a proposal on alpha 1-antitrypsin deficiency for a future PSSAG meeting.
